These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28890199)

  • 1. Distinct cognitive impairments in different disease courses of multiple sclerosis-A systematic review and meta-analysis.
    Johnen A; Landmeyer NC; Bürkner PC; Wiendl H; Meuth SG; Holling H
    Neurosci Biobehav Rev; 2017 Dec; 83():568-578. PubMed ID: 28890199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
    Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
    Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
    Planche V; Gibelin M; Cregut D; Pereira B; Clavelou P
    Eur J Neurol; 2016 Feb; 23(2):282-9. PubMed ID: 25903918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
    Ruano L; Portaccio E; Goretti B; Niccolai C; Severo M; Patti F; Cilia S; Gallo P; Grossi P; Ghezzi A; Roscio M; Mattioli F; Stampatori C; Trojano M; Viterbo RG; Amato MP
    Mult Scler; 2017 Aug; 23(9):1258-1267. PubMed ID: 27738090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom.
    Cortese M; Riise T; Bjørnevik K; Bhan A; Farbu E; Grytten N; Hogenesch I; Midgard R; Smith Simonsen C; Telstad W; Ascherio A; Myhr KM
    Ann Neurol; 2016 Oct; 80(4):616-24. PubMed ID: 27554176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
    Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
    J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS.
    Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Reuling IE; Polman CH
    Neurology; 2004 Jul; 63(2):335-9. PubMed ID: 15277630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study.
    Tillema JM; Hulst HE; Rocca MA; Vrenken H; Steenwijk MD; Damjanovic D; Enzinger C; Ropele S; Tedeschi G; Gallo A; Ciccarelli O; Rovira A; Montalban X; de Stefano N; Stromillo ML; Filippi M; Barkhof F;
    Mult Scler; 2016 Jun; 22(7):901-9. PubMed ID: 26432859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of Polish patients with primary progressive multiple sclerosis.
    Brola W; Sobolewski P; Żak M; Flaga S; Fudala M; Siutka D; Kapica K; Chorąży M; Kułakowska A; Perenc A; Bartosik-Psujek H; Psujek M; Głąbiński A; Pawełczyk M; Gacek S; Potemkowski A
    Mult Scler Relat Disord; 2019 Aug; 33():33-38. PubMed ID: 31146082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment among different clinical courses of multiple sclerosis.
    Brissart H; Morele E; Baumann C; Perf ML; Leininger M; Taillemite L; Dillier C; Pittion S; Spitz E; Debouverie M
    Neurol Res; 2013 Oct; 35(8):867-72. PubMed ID: 23816638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis.
    Nelson F; Akhtar MA; Zúñiga E; Perez CA; Hasan KM; Wilken J; Wolinsky JS; Narayana PA; Steinberg JL
    Mult Scler; 2017 May; 23(6):836-847. PubMed ID: 27613119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balance performance in three forms of multiple sclerosis.
    Soyuer F; Mirza M; Erkorkmaz U
    Neurol Res; 2006 Jul; 28(5):555-62. PubMed ID: 16808889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.
    Prakash RS; Snook EM; Lewis JM; Motl RW; Kramer AF
    Mult Scler; 2008 Nov; 14(9):1250-61. PubMed ID: 18701571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.